These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 858919)

  • 21. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
    Saw CL; Bray RA; Gebel HM
    Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermia enhancement of antibody-complement cytotoxicity for human colon tumor cells.
    Tompkins WA; Rama Rao GV; Pantasatos P; Cain CA
    J Natl Cancer Inst; 1981 Mar; 66(3):453-9. PubMed ID: 6937702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lysis of leukemia cells with a monoclonal antibody-cocktail (e.g. VIP-pool) and human complement].
    Reiners B; Thränhardt H; Häfer R; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):84-96. PubMed ID: 2439421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
    Larkin JM; Norsworthy PJ; A'Hern RP; Eisen TG; Gore ME; Porter CD
    Melanoma Res; 2006 Apr; 16(2):157-63. PubMed ID: 16567971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guinea pig tumor-specific natural antibodies in normal rabbit sera.
    Borsos T; Oanian SH
    J Natl Cancer Inst; 1974 Dec; 53(6):1827-9. PubMed ID: 4436873
    [No Abstract]   [Full Text] [Related]  

  • 30. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry complement-mediated cytotoxicity assay detects baboon xenoantibodies directed to porcine epitopes undetected by hemolytic assay.
    Diaz TM; Moscoso I; Centeno A; Lopez-Pelaez E; Ortega D; Doménech N
    Transpl Immunol; 2004 Dec; 13(4):313-7. PubMed ID: 15589745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.
    Pruett SB; Lackey A
    Clin Exp Immunol; 1987 Sep; 69(3):624-31. PubMed ID: 3117461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural antipig xenoantibody is absent in neonatal human serum.
    Xu H; Edwards NM; Chen JM; Dong X; Michler RE
    J Heart Lung Transplant; 1995; 14(4):749-54. PubMed ID: 7578185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.
    Ray PK; Sundaram K
    Clin Exp Immunol; 1975 Mar; 19(3):529-32. PubMed ID: 1204249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the competitive capacity of monoclonal antibody sensitized human A and B erythrocytes in complement mediated cytotoxicity.
    Bakács T; Ringwald G; Tusnády G; Végh Z; Klein E
    J Clin Lab Immunol; 1990 Aug; 32(4):167-75. PubMed ID: 1966933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial adenine uptake as an assay for cell- or complement-mediated cytotoxicity.
    DeBono DP; Macintyre DE; White DJ; Gordon JL
    Immunology; 1977 Feb; 32(2):221-6. PubMed ID: 844895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumour antibodies in normal mouse sera.
    Martin SE; Martin WJ
    Int J Cancer; 1975 Apr; 15(4):658-64. PubMed ID: 1140865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen.
    Potter VP; Wood WC; Cohen AM; Kornblith PL
    J Surg Oncol; 1984 Jul; 26(3):188-93. PubMed ID: 6547496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.